BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chau J, Zhang J. Tying Small Changes to Large Outcomes: The Cautious Promise in Incorporating the Microbiome into Immunotherapy. Int J Mol Sci 2021;22:7900. [PMID: 34360663 DOI: 10.3390/ijms22157900] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu B, Chau J, Dai Q, Zhong C, Zhang J. Exploring Gut Microbiome in Predicting the Efficacy of Immunotherapy in Non-Small Cell Lung Cancer. Cancers 2022;14:5401. [DOI: 10.3390/cancers14215401] [Reference Citation Analysis]
2 Setlai BP, Mkhize-Kwitshana ZL, Mehrotra R, Mulaudzi TV, Dlamini Z. Microbiomes, Epigenomics, Immune Response, and Splicing Signatures Interplay: Potential Use of Combination of Regulatory Pathways as Targets for Malignant Mesothelioma. Int J Mol Sci 2022;23:8991. [PMID: 36012262 DOI: 10.3390/ijms23168991] [Reference Citation Analysis]
3 Zhang K, Kong X, Li Y, Wang Z, Zhang L, Xuan L. PD-1/PD-L1 Inhibitors in Patients With Preexisting Autoimmune Diseases. Front Pharmacol 2022;13:854967. [DOI: 10.3389/fphar.2022.854967] [Reference Citation Analysis]